In the search of novel radiopharmaceuticals to broaden the spectrum of diagnostic and therapeutic options in the fight against cancer, a series of 99mTc complexes directed against the Epidermal Growth Factor Receptor (EGFR) was presented (Kiritsis et al. 2022). This evidence concerns the gene EGFR and cancer.